Closing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)

In today's trading, shares of Cardiol Therapeutics Inc opened at $2.76 and closed at $2.90. prices ranged from $2.73 to $2.90.

Share prices raised 7.01 percent from the previous day's close of $2.71.

During the day across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).

Trading volume was 63,863 on 220 total trades, with an average volume of 89,009 over the last 5 days.

The TSX overall saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, in the last 12 months, Cardiol Therapeutics Inc's shares have risen 176.19%, while this year, they have risen 163.64%.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $188.05 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Cardiol Therapeutics Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..